VERTEX PHARMACEUTICALS INC / MA
Public company- Headquarters
- BOSTON, Massachusetts
- Ticker
- VRTX
- CIK
- 0000875320
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| new member of the board of directorsDaniel Brennan | Oct 20, 2026 | Appointed |
| CFOJonathan Poole | Sep 1, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- ENANTA PHARMACEUTICALS INC
CEO departs: Jay R. Luly, Ph.D.
- Ernexa Therapeutics Inc.
member of the Board appointed: Robert J. Spiegel, M.D.
- BRISTOL MYERS SQUIBB CO
WARN notice: Princeton, NJ
- JOHNSON & JOHNSON
WARN notice: New Brunswick, NJ
- Executive appointment
new member of the board of directors appointed: Daniel Brennan
Daniel Brennan was named new member of the board of directors of VERTEX PHARMACEUTICALS INC / MA, effective October 20, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Oct 20, 2026Role: new member of the board of directors
- Executive appointment
CFO appointed: Jonathan Poole
Jonathan Poole was named Executive Vice President and Chief Financial Officer of VERTEX PHARMACEUTICALS INC / MA, effective January 1, 2027. Jonathan Poole succeeds Charles F. Wagner, Jr.. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Sep 1, 2026Role: Executive Vice President and Chief Financial Officer
layoffs from Aug 5, 2025
WARN noticeWARN notice: Providence, RI
Vertex Pharmaceuticals filed a WARN notice with the Rhode Island WARN list on Jun 6, 2025 covering 125 workers in Providence. The layoffs take effect on Aug 5, 2025.
Source: Rhode Island WARN list, filed Jun 6, 2025Site: Providence, RI
Workers affected: 125
Last verified Nov 8, 2026